SEC 13F Intelligence

Boxer Capital, LLC / CYTK

Boxer Capital, LLC’s Cytokinetics Inc Position

Does Boxer Capital, LLC own Cytokinetics Inc (CYTK)? Not currently — the last reported position was 2.10M shares worth $111M in Q3 2024; the fund’s latest 13F (Q4 2024) no longer reports it.

Position Value
$111M
Q3 2024
Shares
2.10M
% of Portfolio
+5.44%
Quarters Held
16
position exited

Position History CYTK

Reported value by quarter
Q4 ’20: $44MQ4 ’20Q1 ’21: $49MQ2 ’21: $42MQ2 ’21Q3 ’21: $75MQ4 ’21: $96MQ4 ’21Q1 ’22: $77MQ2 ’22: $83MQ2 ’22Q3 ’22: $102MQ4 ’22: $96MQ4 ’22Q1 ’23: $73,899Q2 ’23: $68,502Q2 ’23Q3 ’23: $62MQ4 ’23: $175MQ4 ’23Q1 ’24: $147MQ2 ’24: $114MQ2 ’24Q3 ’24: $111Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q3 20242.10M$111M+5.44%
Q2 20242.10M$114M+5.99%
Q1 20242.10M$147M+7.27%
Q4 20232.10M$175M+8.74%
Q3 20232.10M$62M+3.29%
Q2 20232.10M$68,502+3.18%
Q1 20232.10M$73,899+3.63%
Q4 20222.10M$96M+5.07%
Q3 20222.10M$102M+5.72%
Q2 20222.10M$83M+5.23%
Q1 20222.10M$77M+3.97%
Q4 20212.10M$96M+3.72%
Q3 20212.10M$75M+2.62%
Q2 20212.10M$42M+1.47%
Q1 20212.10M$49M+1.66%
Q4 20202.10M$44M+1.40%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Boxer Capital, LLC’s full portfolio or all institutional holders of CYTK.